BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Villanueva C, Albillos A, Genescà J, Garcia-Pagan JC, Brujats A, Calleja JL, Aracil C, Bañares R, Morillas RM, Poca M, Peñas B, Augustin S, Abraldes JG, Alvarado E, Torres F, Bosch J; PreDesCI Study Investigators. Bacterial infections adversely influence the risk of decompensation and survival in compensated cirrhosis. J Hepatol 2021;75:589-99. [PMID: 33905794 DOI: 10.1016/j.jhep.2021.04.022] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Reichert MC, Ripoll C. First things first! Can bacterial infections be considered as decompensating events per se? Journal of Hepatology 2021;75:1241-2. [DOI: 10.1016/j.jhep.2021.05.030] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 D'Amico G, Bernardi M, Angeli P. TOWARDS A NEW DEFINITION OF DECOMPENSATED CIRRHOSIS. J Hepatol 2021:S0168-8278(21)00438-4. [PMID: 34157322 DOI: 10.1016/j.jhep.2021.06.018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Onorato L, Monari C, Capuano S, Grimaldi P, Coppola N. Prevalence and Therapeutic Management of Infections by Multi-Drug-Resistant Organisms (MDROs) in Patients with Liver Cirrhosis: A Narrative Review. Antibiotics 2022;11:232. [DOI: 10.3390/antibiotics11020232] [Reference Citation Analysis]
4 Hagström H, Thiele M, Simon TG, Sharma R, Röckert Tjernberg A, Roelstraete B, Söderling J, Ludvigsson JF. Risk of infections and their role on subsequent mortality in biopsy-proven alcohol-related liver disease. United European Gastroenterol J 2022. [PMID: 35088575 DOI: 10.1002/ueg2.12200] [Reference Citation Analysis]
5 Kremer WM, Gairing SJ, Kaps L, Ismail E, Kalampoka V, Hilscher M, Michel M, Siegel E, Schattenberg JM, Galle PR, Sprinzl MF, Wörns MA, Nagel M, Labenz C. Characteristics of bacterial infections and prevalence of multidrug-resistant bacteria in hospitalized patients with liver cirrhosis in Germany. Ann Hepatol 2022;:100719. [PMID: 35460883 DOI: 10.1016/j.aohep.2022.100719] [Reference Citation Analysis]
6 Villanueva C, Bosch J; PREDESCI Study Investigators. Reply to: "First things first! Can bacterial infections be considered as decompensating events per se?". J Hepatol 2021:S0168-8278(21)01956-5. [PMID: 34358568 DOI: 10.1016/j.jhep.2021.07.028] [Reference Citation Analysis]
7 Xiao Y, Yang J, Fu Z, Xiong Z, Zhang C, He D, Zhou Z, Li N, Yuan J, Shi W. Inhibition of Galectin-3 Impairs Antifungal Immune Response in Fungal Keratitis. Disease Markers 2022;2022:1-11. [DOI: 10.1155/2022/8316004] [Reference Citation Analysis]